跳至主要内容
临床试验/NCT02021864
NCT02021864Unknown不适用

Effect of Treatment of Vitamin D Deficiency During Pregnancy on Hypocalcemia

Dr. Sima Hashemipour1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
percentage of hypocalcemic subjects at the ens of study

研究概览

简要总结

  • Pregnant women in 24-26 gestational week will be recruited.Serum calcium and 25(OH)D will be evaluated and women with mild hypocalcemia (serum calcium 8-8.6 mg/dl) and 25(OH)D less than 30ng/ml will be entered to study. .
  • Excluding criteria are: gestational diabetes or diabetes before pregnancy, severe preeclampsia, chronic hypertension, fetal anomaly, oligohydramnios or polyhydramnios, parathyroid disorders, hepatic or renal diseases, malnutrition , use of anti- convulsive and immunosuppressive drugs.
  • Participants will randomly assigned in to two groups of intervention and control groups .Randomization will be done by random number generator. Intervention group will receive weekly vitamin D3, 50,000 unit for 8 weeks plus daily prenatal multivitamin containing elemental calcium 250 mg/day and vitamin D3 400 unit , control group will receive daily prenatal multivitamin.
  • At the time of delivery, serum calcium, 25(OH)D of mothers, maternal weight gain during study , Serum calcium and 25(OH)D of newborns and neonatal growth indices ( length, weight, head circumference ) will be compared between two groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
16 Years 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • gestational age of 24-26weeks,mild hypocalcemia (ca=8-8.6mg/dl),singleton pregnancy, body mass index (BMI) of 19-26 -

排除标准

  • moderate to sever hypocalcemia(ca<8mg/dl), gestational diabetes or diabetes before pregnancy, severe preeclampsia, chronic hypertension, fetal anomaly, oligohydramnios or polyhydramnios, parathyroid disorders, hepatic or renal diseases, malnutrition , use of anti- convulsive and immunosuppressive drugs

研究组 & 干预措施

vitamin D3, prenatal multivitamin

Experimental

vitamin D3 50,000 unit/week for 8 weeks, daily prenatal multivitamin containing elemental calcium 250 mg/day and vitamin D3 400 unit

干预措施: vitamin D3 50,000 unit (Drug)

vitamin D3, prenatal multivitamin

Experimental

vitamin D3 50,000 unit/week for 8 weeks, daily prenatal multivitamin containing elemental calcium 250 mg/day and vitamin D3 400 unit

干预措施: prenatal multivitamin (Drug)

prenatal multivitamin

Active Comparator

daily prenatal multivitamin containing elemental calcium 250 mg/day and vitamin D3 400 unit

干预措施: prenatal multivitamin (Drug)

结局指标

主要结局

percentage of hypocalcemic subjects at the ens of study

时间窗: 12-14 weeks

women in 24-26 weeks of pregnancy will be enrolled.Outcomes will be measured at delivery time.

次要结局

  • Changing of maternal mean calcium level(12-14 weeks)

研究者

发起方
Dr. Sima Hashemipour
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Sima Hashemipour

assistant professor of endocrinology and metabolism

Sina Hospital, Iran

研究点 (1)

Loading locations...

相似试验